Synthesis and screening of novel inositol phosphonate derivatives for anticancer functions in vitro

被引：0

作者：

WenBin Chen ^{[1
]}

JianBing Liu ^{[1
]}

DaoLei Dou ^{[2
]}

FanBo Song ^{[1
]}

LuYuan Li ^{[2
]}

Zhen Xi ^{[1
]}

机构：

[1] State Key Laboratory of Elemento-Organic Chemistry,Department of Chemical Biology,Nankai University

[2] State Key Laboratory of Medicinal Chemical Biology,College of Pharmacy,Nankai University

来源：

ChineseChemicalLetters | 2015年 / 26卷 / 03期

关键词：

Inositol phosphonates; Anticancer; Non-small cell lung cancer; Nucleophilic substitution; Arbuzov rearrangement;

D O I：

暂无

中图分类号：

O627.51 [磷有机化合物]; TQ460.1 [基础理论];

学科分类号：

070303 ; 081704 ; 1007 ;

摘要：

Phosphonates have been frequently used as suitable isosteric and isoelectronic replacements for biologically important phosphates in the development of drugs or drug candidates because of their stability toward the action of phosphatases and other enzymes.In this paper,12 mono-phosphonate inositol compounds were prepared with phosphonate instead of phosphate by two kinds of strategies,nucleophilic substitution and Arbuzov rearrangement,respectively.All compounds were evaluated in vitro for their activity against non-small cell lung cancer(NSCLC) cell line A549.Two compounds(3ac and 3bb) exhibited good antitumor activity at 10 mg/m L.

引用

页码：329 / 333

页数：5

共 11 条

[1]

Synthesis and Biological Evaluation of Novel 1,2,3‐Triazolonucleotides[J] . Iwona E. G?owacka,Jan Balzarini,Andrzej E. Wróblewski.Arch. Pharm. Pharm. Med. Chem. . 2013 (4)

[2]

Synthesis and antitumour activity of inositol phosphonate analogues[J] . Fanbo Song,Jing Zhang,Quanbin Cui,Ting Wang,Wenbin Chen,Luyuan Li,Zhen Xi.Tetrahedron Letters . 2011 (9)

[3]

Regulation of nuclear processes by inositol polyphosphates[J] . John D. York.BBA - Molecular and Cell Biology of Lipids . 2006 (5)

[4]

Inositol pyrophosphates: metabolism and signaling[J] . M. Bennett,S. M. N. Onnebo,C. Azevedo,A Saiardi.Cellular and Molecular Life Sciences . 2006 (5)

[5]

Structure–activity relationship of Aza-steroids as PI-PLC inhibitors[J] . Wenge Xie,Hairuo Peng,Deog-Il Kim,Mark Kunkel,Garth Powis,Leon H. Zalkow.Bioorganic ＆ Medicinal Chemistry . 2001 (5)

[6] 3β-hydroxy-6-aza-cholestane and related analogues as phosphatidylinositol specific phospholipase C (PI-PLC) inhibitors with antitumor activity [J].

Xie, WG ;

Peng, HR ;

Zalkow, LH ;

Li, YH ;

Zhu, C ;

Powis, G ;

Kunkel, M .

BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (04) :699-706

[7] Binding of inositol phosphate to DNA-PK and stimulation of double-strand break repair [J].

Hanakahi, LA ;

Bartlet-Jones, M ;

Chappell, C ;

Pappin, D ;

West, SC .

CELL, 2000, 102 (06) :721-729

[8]

The assembly of β-methylene-TAD, a metabolically stable analogue of the antitumor agent tad, by the stepwise esterification of monodeprotected methylenebis-（phosphonate） benzyl esters under mitsunobu conditions[J] . Hisafumi Ikeda,Elie Abushanab,Victor E. Marquez.Bioorganic ＆ Medicinal Chemistry Letters . 1999 (21)

[9] Inhibition of myo-inositol monophosphatase isoforms by aromatic phosphonates [J].

Ganzhorn, AJ ;

Hoflack, J ;

Pelton, PD ;

Strasser, F ;

Chanal, MC ;

Piettre, SR .

BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (10) :1865-1874

[10]

Adenophostin-medicated quantal Ca 2+ release in the purified and reconstituted inositol 1,4,5-trisphosphate receptor type 1[J] . Junji Hirota,Takayuki Michikawa,Atsushi Miyawaki,Masaaki Takahashi,Kazuhiko Tanzawa,Ichiro Okura,Teiichi Furuichi,Katsuhiko Mikoshiba.FEBS Letters . 1995 (2)

← 1 2 →